Managing Comorbidity in RA: Multidisciplinary Care Team Model Essential
Since the management of comorbidities goes beyond the scope of rheumatoid arthritis (RA), researchers highlight the need for a multidisciplinary care team model.
All articles by Rheumatology Advisor Contributing Writer
Biopsy-Informed Management Safely, Accurately Predicts Flares in Lupus Nephritis
This study reports the long-term renal outcomes of kidney biopsies performed at prespecified intervals to determine the safety and accuracy of tapering of maintenance immunosuppression.
Diagnostic Delay Not Associated With Visual Symptoms in Giant Cell Arteritis
The study compared general and giant cell arteritis-specific characteristics in patients with and without visual symptoms, and examined the role of diagnostic delay in patients with giant cell arteritis experiencing current visual symptoms.
Updated 2019 EULAR Recommendations for Vaccination in Adults With Autoimmune Inflammatory Rheumatic Diseases
A steering committee put together by EULAR has updated recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases.
No Improvement in Bone Mineral Density With TNFi Therapy in RA With Osteoporosis
A retrospective study was performed to investigate the effects of TNFi on bone mineral density in patients with RA who received bisphosphonate.
2019 EULAR/ACR Recommendations for SLE Classification Criteria
New 2019 classification criteria for systemic lupus erythematosus was jointly developed by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR).
Hydroxychloroquine Use Not Linked With Risk for Alzheimer Disease
Investigators addressed the association between long-term use of hydroxychloroquine therapy and the risk for Alzheimer disease.
First-Time Initiation of TNFi Therapy Shows Positive Disease Outcomes in Axial Spondyloarthritis
Investigators reviewed drug retention and response rates in patients with axial spondyloarthritis after their first initiation with tumor necrosis factor inhibitors.
Updated 2019 ACR Recommendations for Treatment of Ankylosing Spondylitis, Nonradiographic Axial SpA
Based on new evidence and an expert consensus, the American College of Rheumatology (ACR), the Spondylitis Association of America, and the Spondyloarthritis Research and Treatment Network released updated recommendations for the treatment of axial spondyloarthritis (SpA), which comprises ankylosing spondylitis (AS) and nonradiographic axial SpA. This report was published in Arthritis Care & Research. A systematic…
TNFi Response Rates, Drug Survival Similar Across Trial Inclusion, Exclusion Groups With PsA
The study compared the benefits and drug survival of patients with psoriatic arthritis who did not fulfill vs those who did fulfill the inclusion criteria for randomized controlled trials for the TNF inhibitor chosen for their treatment.
Next post in Psoriatic Arthritis
